NEW YORK STATE COMMON RETIREMENT FUND - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 83 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1
-98.6%
304
-97.2%
0.00%
Q2 2023$73
-64.0%
10,951
+0.6%
0.00%
Q1 2023$203
-18.5%
10,885
-5.9%
0.00%
Q4 2022$249
-99.8%
11,571
-0.1%
0.00%
Q3 2022$137,000
-9.9%
11,582
+0.5%
0.00%
Q2 2022$152,000
-36.9%
11,525
-0.2%
0.00%
Q1 2022$241,000
+2.6%
11,549
-0.2%
0.00%
Q4 2021$235,000
-33.0%
11,574
+0.2%
0.00%
Q3 2021$351,000
-21.1%
11,551
-24.6%
0.00%
Q2 2021$445,000
-53.3%
15,310
-30.6%
0.00%
-100.0%
Q1 2021$953,000
+73.3%
22,070
+85.5%
0.00%0.0%
Q4 2020$550,000
+30.6%
11,900
+22.7%
0.00%0.0%
Q3 2020$421,000
-18.1%
9,7000.0%0.00%0.0%
Q2 2020$514,000
+264.5%
9,700
+54.0%
0.00%
Q1 2020$141,000
+5.2%
6,300
-31.5%
0.00%
Q4 2019$134,000
+106.2%
9,2000.0%0.00%
Q3 2019$65,000
-35.6%
9,2000.0%0.00%
Q2 2019$101,0009,2000.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders